Draig Therapeutics Ltd
DT-101
Major Depressive Disorder (MDD)
Countdown
328days
Phase 2 readout · ~ May 31, 2027 estimated
What's at stake
Phase 2 trial results for DT-101 in Major Depressive Disorder (MDD) are due ~ May 31, 2027. A clean hit validates the program; a miss can gap the stock down hard.
Primary source
· ClinicalTrials.gov
verified 15h ago
“CT.gov NCT07610473: Phase 2 trial, sponsor Draig Therapeutics Ltd, drug DT-101. Primary completion date 2027-05 (estimated).”